Pharmafile Logo

US Congress

- PMLiVE

FDA approves GSK’s combo cancer treatment

US regulator backs Mekinist and Tafinlar to treat melanoma

- PMLiVE

FDA to assess safety of Boehringer’s Pradaxa

US regulator plans study to compare the anticoagulant with warfarin

- PMLiVE

FDA backs a brace of allergy immunotherapies

Merck & Co and Stallergenes win drug approvals in US

- PMLiVE

Senior hire for 3D Communications

Allison May Rosen joins as communications lead for FDA Advisory Committee projects

- PMLiVE

FDA panel backs Takeda’s inflammatory bowel disease drug

Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis

FDA reins in Google-backed genetics company 23andMe

Health-related genetic test service put on hold pending US regulatory review

- PMLiVE

Auxilium’s Xiaflex cleared in US for erection disorder

FDA approval to treat Peyronie's disease

- PMLiVE

Baxter re-files HyQvia for immunodeficiency in US

Pharma company provides FDA with more data

- PMLiVE

FDA backs new formulation of Noxafil

Merck wins US approval for delayed-release version of anti-infective

- PMLiVE

FDA lifts restrictions on Avandia use

US regulator says GSK’s diabetes drug does not increase heart attack risk

- PMLiVE

BTG rises on FDA approval of varicose vein therapy

Varithena receives green light in US

- PMLiVE

ViiV’s Tivicay for HIV on course for EU approval

More positive news for GSK, Pfizer and Shionogi joint venture

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links